U.S.
-
Sports Medicine
ABANZA Strengthens US Operations with Established Orthopedic Industry Expert, John Rizzo, as Executive Vice President
NAVARRA, Spain, Jan. 22, 2024 /PRNewswire/ — ABANZA is excited and honored to announce the strategic addition of Executive Vice President for US operations, JOHN…
Read More » -
Spine
Spine Pain Industry Analysis in United States Revenue to Total US$ 10,962.7 Million by 2033 amid Rising Prevalence of Back Pain: Future Market Insights, Inc.
The increasing incidence of back pain in the United States is a key driver fueling demand for various treatment options.…
Read More » -
Regulatory
Stratus® Medical adds fifth U.S. patent and two Canadian patents to its 29-patent global IP portfolio for the NIMBUS® Electrosurgical RF Multitined Expandable Electrode
MAGNOLIA, Texas, Nov. 8, 2023 /PRNewswire/ — Stratus® Medical, a company focused on improving clinical outcomes for chronic pain patients by advancing radiofrequency…
Read More » -
Biologics
DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells
Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding SALT LAKE CITY, Oct. 18, 2023 /PRNewswire/ — DiscGenics, Inc., a privately held, late-stage…
Read More » -
Biologics
2,000 patients treated with OssDsign® Catalyst in the U.S.
Uppsala, September 13, 2023. OssDsign AB (publ.) today announces that the company’s orthobiologic business continues to accelerate its successful commercialization…
Read More » -
Extremities
Inside information: Bioretec enters into the U.S. distribution agreement with Spartan Medical for the RemeOs™ screws
TAMPERE, Finland, Sept. 12, 2023 /PRNewswire/ — Bioretec Ltd, a pioneering company dedicated to advancing biodegradable orthopedic implants, has signed a distribution…
Read More » -
Neuro
Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8® in the United States
Randomized controlled clinical trial expected to validate effectiveness of ReActiv8® Restorative NeurostimulationTM vs. optimal medical management DUBLIN, August 29, 2023–(BUSINESS WIRE)–Mainstay Medical…
Read More » -
Sports Medicine
CartiHeal Announces First Commercial Implantation of Agili-C™ in the US
Dr. Ken Zaslav KFAR SABA, Israel, July 26, 2023 /PRNewswire/ — CartiHeal Ltd., developer of implants for the treatment of cartilage and osteochondral defects…
Read More » -
Biologics
Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone
Hyalofast – a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair – is marketed in over 35 countries outside the U.S. where it…
Read More » -
Spine
1,000 patients treated with OssDsign® Catalyst in the U.S.
Uppsala, May 9, 2023 – OssDsign AB (publ.) today announces that 1,000 patients have been treated in the U.S. with…
Read More »